PDL BioPharma, Inc., an Incline Village company that manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries, announced that John P. McLaughlin, PDL’s president and chief executive officer, will present at two investor conferences in September.
McLaughlin will attend the Rodman & Renshaw 19th Annual Global Investment Conference Monday, Sept. 11, and the 2017 Cantor Fitzgerald Global Healthcare Conference Monday, Sept. 25, both in New York City.
